AUTL position history
The shares of Autolus Therapeutics (AUTL) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 496,150 shares, $2.1M, 0.54% of portfolio, New
- 2022 Q2: 496,150 shares, $1.4M, 0.38% of portfolio
- 2022 Q3: 496,150 shares, $1.1M, 0.29% of portfolio
- 2022 Q4: 1,176,150 shares, $2.2M, 0.63% of portfolio, Add +137.1%
- 2023 Q1: 1,176,150 shares, $2.2M, 0.65% of portfolio
- 2023 Q2: 930,394 shares, $2.2M, 0.61% of portfolio, Reduce −20.9%
- 2023 Q3: 928,253 shares, $2.2M, 0.67% of portfolio, Reduce −0.2%
- 2023 Q4: 191,070 shares, $1.2M, 0.29% of portfolio, Reduce −79.4%
- 2024 Q1: 216,667 shares, $1.4M, 0.31% of portfolio, Add +13.4%
- 2024 Q2: 346,667 shares, $1.2M, 0.29% of portfolio, Add +60.0%
- 2024 Q3: 486,667 shares, $1.8M, 0.42% of portfolio, Add +40.4%
- 2024 Q4: 586,667 shares, $1.4M, 0.35% of portfolio, Add +20.5%
- 2025 Q1: 586,667 shares, $909K, 0.26% of portfolio
- 2025 Q2: 425,616 shares, $970K, 0.27% of portfolio, Reduce −27.5%
- 2025 Q3: 179,316 shares, $292K, 0.07% of portfolio, Reduce −57.9%
- 2025 Q4: 179,316 shares, $357K, 0.08% of portfolio
- 2026 Q1: 179,316 shares, $247K, 0.06% of portfolio
- 2026 Q2: 179,316 shares, $287K, 0.05% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|